PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys
Share |

Vetting Celebrity Spokespersons to Ensure Return on Investment
Ambre Morley In this 2-minute audio snippet, Ambre Morley, Associate Director, Product Communications, Novo Nordisk, talks about vetting Paula Deen as a paid celebrity spokesperson for the Novo Victoza diabetes drug franchise and the importance of measuring celebrity return on investment (ROI).

Meanwhile, listen to this Pharma Marketing Talk conversation with Morley about why her company teamed up with Paula Deen.

Aired LIVE on: Wednesday, January 18, 2012

Listen to internet radio with Pharmaguy on Blog Talk Radio

Pharmaguy Calls for Novo to Dump Deen (they did!)

Links to More Information

Messages from Our Sponsors

Contact Information
Pharma Marketing Network

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.